Research on the pathogenis and protection of Atherosclerosis

动脉粥样硬化发病机制及防治研究

基本信息

  • 批准号:
    62570393
  • 负责人:
  • 金额:
    $ 1.15万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for General Scientific Research (C)
  • 财政年份:
    1987
  • 资助国家:
    日本
  • 起止时间:
    1987 至 1988
  • 项目状态:
    已结题

项目摘要

1. Research on the Pathogenesis of Atherosclerosis: Proliferation of vascular smooth muscle cells (VSMC) and deposition of lipid is important for the pathogenesis of atherosclerosis.1) Vascular smooth muscle cells from rat aorta contaied a specific receptor for the 1,25-dihydroxyvitamin D_3 and it stimulated the proliferation and suppressed the synthesis of glycosaminoglycan.2) Platelet derived growth factor (PDGF) increased intracellular Ca^<2+> concentration ([Ca^<2+>] i) in rabbit chondrocytes and stimulated the synthesis of DNA and glycosaminoglycan. Suramin, an antagonist of PDGF, suppressed the increase of [Ca^<2+>] i and the synthesis of DNA.3) Low density lipoprotein (LDL) increased [Ca^<2+>] i. LDL caused a release of Ca^<2+> from intracellular Ca^<2+> store through production of inositole trisphosphate (iP_3).4) A specific receptor for PDGF existed in the basolateral membrane of dog kidney and PDGF stimulated Ca^<2+>- ATPase.2. Reaserch for the effects of various chemical compounds on the intracellular Ca^<2+> signal system.1) Prostaglandin F2 and angiotensin II (AII), both of which are strong vasoconstrictor, increased [Ca^<2+>] i in VSMC and caused the release of Ca^<2+> from intracellular Ca^<2+> store. Nicorandil, a vasodilator, suppressed the increase of [Ca^<2+>] i induced by prostaglandin F2 and AII.2) Valinomycin, a potassium ionophore, suppressed the release of CA^<2+> from intracellular Ca^<2+> store induced by AII but did not suppress those induced by ionomycin, a Ca^<2+> ionophore. However valinomycin did not sauppress the production of iP_3 induced by AII.3) Nitroglycerin and nicorandil, which are nitrates, stimulated the activities of Ca^<2+>-ATPase in the microsmal fraction of porcine coronary artery smooth muscle cells, but Ca^<2+> channel blockers did not.
1.动脉粥样硬化的发病机制研究:血管平滑肌细胞(VSMC)的增殖和脂质沉积在动脉粥样硬化的发病机制中起重要作用。1)大鼠主动脉血管平滑肌细胞含有1,25-二羟维生素D_3刺激细胞增殖,抑制糖胺聚糖的合成; 2)血小板源性生长因子(PDGF)增加细胞内Ca ~(2+)>浓度([Ca^<2+>] i),并刺激DNA和糖胺聚糖的合成。PDGF拮抗剂苏拉明可抑制[Ca^<2+>] i的升高和DNA的合成; 3)低密度脂蛋白(LDL)可升高[Ca^<2+>] i。LDL通过产生三磷酸肌醇(iP_3)引起细胞内Ca^<2+>库中Ca^<2 +>的释放。4)狗肾基底外侧膜上存在一种PDGF的特异性受体,并且PDGF刺激Ca^<2+>-ATP酶。2. 1)前列腺素F2和血管紧张素II(Angiotensin II,AII)均为强缩血管剂,可使VSMC [Ca^2+] i增加,引起细胞内Ca^2+库释放Ca^2+。2)钾离子载体缬氨霉素抑制AII诱导的细胞内Ca ^2+库释放Ca ^2+,但不抑制钙离子载体离子霉素诱导的细胞内Ca^2+库释放Ca^2+。3)硝酸甘油和尼可地尔对猪冠状动脉平滑肌细胞的Ca^<2+>-ATP酶活性有促进作用,而Ca^<2 +>通道阻断剂则无此作用。

项目成果

期刊论文数量(51)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Koh Eio.: Life Sciences. 42. 215-223 (1988)
Koh Eio.:生命科学。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Fukuo, Keisuke: "Effects of prostaglandins on the cytosolic free calcium concentration in vascular smooth muscle cells." Biochem. Biophys. Res. Commun.136. 247-252 (1986)
Fukuo,Keisuke:“前列腺素对血管平滑肌细胞胞质游离钙浓度的影响。”
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Fukuo, Keisuke.: "Inhibitory effects of suramin on inductions by platelet-derived growth factor of mitogenesis and increase in cytosolic Ca^<2+> in chondrocytes." Cell Calcium. in press. (1989)
Fukuo, Keisuke.:“苏拉明对血小板衍生生长因子诱导有丝分裂和软骨细胞中胞质 Ca^2 增加的抑制作用。”
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Morita Ryuhei.: "Low density lipoprotein and apoprotein B induce increase in inositol trisphosphate and cytosolic free Ca^<2+> in vascular smooth muscle cells." Biochemistry International. 18. 647-653 (1989)
Morita Ryuhei.:“低密度脂蛋白和脱辅基蛋白 B 诱导血管平滑肌细胞中肌醇三磷酸和胞质游离 Ca^2 的增加。”
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Koh, Eio: "Effects of nitrates and calcium channel blockers on Ca^<2+>-ATPase in the Mecrosomal fraction of porcine coronary artery smooth muscle cells." Cell Calcium.8. 397-410 (1987)
Koh,Eio:“硝酸盐和钙通道阻滞剂对猪冠状动脉平滑肌细胞巨大体部分中Ca 2+ -ATP酶的影响。”
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

ONISHI Toshio其他文献

ONISHI Toshio的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('ONISHI Toshio', 18)}}的其他基金

A Study on the Construction of Promotion System of the Liquidation of Farmland in Producing Areas of Ume ; Case of Wakayama Prefecture
梅产区耕地流转促进体系构建研究
  • 批准号:
    20580246
  • 财政年份:
    2008
  • 资助金额:
    $ 1.15万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Movement and Mechanism of Horticultural Producing Reorganization under Enlargement and Internationalization of the Distribution
布局扩大化、国际化下的园艺生产重组动作与机制
  • 批准号:
    10660216
  • 财政年份:
    1998
  • 资助金额:
    $ 1.15万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)

相似海外基金

EFR3: Novel gatekeeper of cell proliferation
EFR3:细胞增殖的新型看门人
  • 批准号:
    DP240102729
  • 财政年份:
    2024
  • 资助金额:
    $ 1.15万
  • 项目类别:
    Discovery Projects
NEM-EMERGE: An integrated set of novel approaches to counter the emergence and proliferation of invasive and virulent soil-borne nematodes
NEM-EMERGE:一套综合的新方法来对抗入侵性和剧毒土传线虫的出现和扩散
  • 批准号:
    10080598
  • 财政年份:
    2024
  • 资助金额:
    $ 1.15万
  • 项目类别:
    EU-Funded
An integrated set of novel approaches to counter the emergence and proliferation of invasive and virulent soil-borne nematodes
一套综合的新方法来对抗入侵性和剧毒土传线虫的出现和扩散
  • 批准号:
    10093554
  • 财政年份:
    2024
  • 资助金额:
    $ 1.15万
  • 项目类别:
    EU-Funded
Elucidating the mechanism that measures mitotic duration to prevent proliferation of defective cells
阐明测量有丝分裂持续时间以防止缺陷细胞增殖的机制
  • 批准号:
    23K05773
  • 财政年份:
    2023
  • 资助金额:
    $ 1.15万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Supply and Demand: Oxygen and Workload Regulate Cardiomyocyte Proliferation
供需:氧气和工作量调节心肌细胞增殖
  • 批准号:
    10572541
  • 财政年份:
    2023
  • 资助金额:
    $ 1.15万
  • 项目类别:
Decoding the epigenetic landscape that delineates T cell homeostatic proliferation from uncontrolled growth”
解码表观遗传景观,描绘 T 细胞稳态增殖与不受控制的生长 –
  • 批准号:
    10644128
  • 财政年份:
    2023
  • 资助金额:
    $ 1.15万
  • 项目类别:
Regulation of cardiomyocyte proliferation by the Reptin ATPase
Reptin ATP酶对心肌细胞增殖的调节
  • 批准号:
    10747229
  • 财政年份:
    2023
  • 资助金额:
    $ 1.15万
  • 项目类别:
LEAP - Legal Ecosystem for AI Proliferation
LEAP - 人工智能扩散的法律生态系统
  • 批准号:
    10075974
  • 财政年份:
    2023
  • 资助金额:
    $ 1.15万
  • 项目类别:
    Grant for R&D
Regulation of RAS driven cellular proliferation by SHOC2 and the MRAS GTPase
SHOC2 和 MRAS GTPase 调节 RAS 驱动的细胞增殖
  • 批准号:
    478191
  • 财政年份:
    2023
  • 资助金额:
    $ 1.15万
  • 项目类别:
    Operating Grants
IL-13-induced SFRP1 requires STAT3 to regulate esophageal epithelial proliferation and Basal Zone Hyperplasia in EoE
IL-13诱导的SFRP1需要STAT3来调节EoE中的食管上皮增殖和基底区增生
  • 批准号:
    10677306
  • 财政年份:
    2023
  • 资助金额:
    $ 1.15万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了